One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v124.21.673.673
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 6, 2014 |
 Citations: 10 |
Affiliation: Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, Baylor University, Wayne State University, Oregon Health & Science University, Loyola University Medical Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Ospedaliera Universitaria Senese, Istituti di Ricovero e Cura a Carattere Scientifico, Ospedale Policlinico San Martino, Russian Cancer Research Center NN Blokhin, University of Minnesota Medical Center, Huntsman Cancer Institute, Addenbrooke's Hospital, Takeda (United States), Seagen (United States), The Maria Sklodowska-Curie National Research Institute of Oncology
The Aethera Trial: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Brentuximab Vedotin in the Treatment of Patients at Risk of Progression Following Autologous Stem Cell Transplant for Hodgkin Lymphoma
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
